You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

Indiana Senate Passes Legislation to Ensure Safe Access to Biosimilar Therapies

Jan 30 2014
Patients Should Be Informed if Doctor's Prescription Changed

Farm Bill Energy Title Will Support Employment Opportunities in Renewable Energy and Chemicals

Jan 29 2014
BIO today thanks House champions of the Farm Bill energy title and congratulates them on final passage of the bill.

EPA Should Not Undercut Advanced and Cellulosic Biofuel Development With Proposed Changes to RFS

Jan 28 2014
The Environmental Protection Agency (EPA) lacks authority to waive the overall 2014 volume requirements for the Renewable Fuel Standard, particularly when production and supply of advanced biofuels continues to grow, BIO emphasized in official comments filed today.

New Farm Bill Provides Long-Overdue Eligibility for Renewable Chemicals

Jan 27 2014
The Farm Bill conference report contains significant funding for renewable energy programs, allows renewable chemical technologies to access the programs, and supports purpose grown energy crops.

Registration for the 2014 BIO International Convention Now Open

Jan 27 2014
Updated Convention features include new session formats, premier networking opportunities and improved programming

Members of Congress Write EPA Administrator in Support of RFS

Jan 23 2014
Thirty-one Senators and 31 Congressmembers signed letters to EPA Administrator Gina McCarthy protesting the proposed rule for the 2014 Renewable Fuel Standards.

16th Annual BIO CEO & Investor Conference to Highlight 2014 Biotech Outlook, Timely Business Development Issues and Hot Therapeutic Topics

Jan 23 2014
BIO announced plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 16th annual BIO CEO & Investor Conference.

Legislation Introduced To Communicate Prescription Changes to Patients & Physicians

Jan 22 2014
BIO and WBBA commend the Washington State House and Senate for continuing to advance legislation designed to create a pathway for the substitution of interchangeable biologic medicines.

BIO Lauds House and Senate Omnibus Spending Agreement

Jan 14 2014
Spending plan would enable the FDA to access $85 million in sequestered user fees

BIO Supports Bipartisan Congressional Trade Priorities Act of 2014

Jan 13 2014
BIO expresses strong support for the “Bipartisan Congressional Trade Priorities Act of 2014”, which was issued by a bipartisan group of leaders from the Senate Finance and House Ways and Means Committee last week.